Heart Disease Trial, Recruiting NCT04583800 Sponsor: University Hospital, Lille Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04583800
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • You must be an adult (18 years or older).
  • You must be able to understand the information given about the trial and be able to agree or disagree to take part.
  • You must have been diagnosed with type 2 diabetes and must NOT have heart failure at stage B or above.
  • You must be covered by a social security (health insurance) scheme.
  • You must be willing to sign a consent form to participate in the trial.

Who may not be able to join:

  • People who have been diagnosed with dementia may not be eligible.
  • People who have heart failure at stage B or above may not be eligible (confirm with trial site for what this means in your situation).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 June 2021
Est. completion
1 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Heart failure (≥ stade B).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov